Obesidade e síndrome metabólica na infância e adolescência

Autores

  • Cecília Lacroix de OLIVEIRA Universidade Federal de São Paulo
  • Marco Túlio de MELLO Universidade Federal de São Paulo
  • Isa de Pádua CINTRA Universidade Federal de São Paulo
  • Mauro FISBERG Universidade Federal de São Paulo

Palavras-chave:

obesidade, criança, adolescente, resistência à insulina, hiperlipidemia, hipertensão, síndrome metabólica

Resumo

Nas últimas décadas a prevalência da obesidade vem apresentando um aumento em vários países ao redor do mundo. Este fato é preocupante, já que o excesso de gordura corporal, principalmente a abdominal, está diretamente relacionado com alterações do perfil lipídico, com o aumento da pressão arterial e a hiperinsulinemia, considerados fatores de risco para o desenvolvimento de doenças crônicas, como o diabetes melito tipo 2 e as doenças cardiovasculares. Níveis elevados de leptina e de ácido úrico e a alteração dos fatores fibrinolíticos também têm sido observados em indivíduos obesos. O conjunto destas alterações tem sido descrito como “síndrome metabólica” ou “síndrome da resistência à insulina”, já que a hiperinsulinemia tem um papel importante no desenvolvimento dos outros componentes da síndrome metabólica. Entretanto, questiona-se se estas alterações já estão presentes em crianças e adolescentes obesos. Este artigo descreve a fisiopatologia dos componentes da síndrome metabólica e esclarece como este processo ocorre na faixa etária mais jovem.

Referências

Wang Y, Monteiro C, Popkin BM. Trends of obesity and underweight in older children and adolescents in the United States, Brazil, China, and Russia. Am J Clin Nutr 2002; (75):971-7.2. Balaban G, Silva GAP. Prevalência de sobrepeso em crianças e adolescentes de uma escola da rede privada de Recife. J Pediatria 2001; 77(2):96-100.

Stamler J. Epidemic obesity in the United States. Arch Intern Med 1993; 153:1040-4.

Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH. Long-term morbity and mortality of overweight adolescents: a follow-up of the Harvard Growth Study 1922 to 1935. N Engl J Med 1992; 327:1350-5.

Srinivasan SR, Bao W, Wattigney WA, Berenson GS. Adolescent overweights associated with adult overweight and related multiple cardiovascular risk factors: The Bogalusa Study. Metabolism 1996; 45:235-40.

Styne DM. Childhood and adolescent obesity. Prevalence and significance. Pediatr Clin North Am 2001; 48(4):823-53.

Freedman DS, Dietz WH, Srinivasan SR, Berenson GS. The relation of overweight to cardiovascular risk factors among children and adolescents: The Bogalusa Heart Study. Pediatrics 1999; 103(6): 1175-82.

Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999; 104(6): 787-94.

Sinha R, Fisch G, Teague B, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002; 346(11):802-10.

Bao W, Srinivasan SR, Berenson GS. Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults. Circulation 1996; 93:54-9.

Després JP, Lemieux I, Tchernof A, Coullard C, Pascot A, Lemieux S. Distribution et métabolisme des masses grasses. Diabetes Metab 2001; 27(2):209-14.

Ronnemaa T, Knip M, Lautala P, Viikari J, Uhari M, Leino A, et al. Serum insulin and other cardiovascular risk indicators in children, adolescents and young adults. Ann Med 1991; 23:67-72.

Valle M, Gascón F, Martos R, Ruz FJ, Bermudo F, Morales R, et al. Metabolic cardiovascular syndrome in obese prepubertal children: the role of high fasting insulin levels. Metabolism 2002; 51(4): 423-8.

Ferrannini E, Buzzigoli G, Bonadonna R, et al. Insulin resistance in essential hypertension. N Engl J Med 1987; 317(6):350-7.

Sheehan MT, Michael DJ. Metabolic complications of obesity. Med Clin North Am 2000; 84(2): 363-85.

Lauer RM, Burns TL, Clarke WR, et al. Childhood predictors of future blood pressure. Hypertension1991; 18(2):174-81.

Raitakari OT, Porkka KVK, Ronnemaa T, Knip M, Uhari M, Akerblom HK, et al. The role of insulin in clustering of serum lipids and blood pressure in children and adolescents. Diabetologia 1995; 38(9):1042-50.

Cruz ML, Bergman RN, Goran MI. Unique effect of visceral fat on insulin sensivity in obese Hispanic children with a family history of type 2 diabetes. Diabetes Care 2002; 25(9):1631.

Hak AE, Stehouwer CD, Bots ML, et al. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol 1999; 19(8):1986-91.

Sudi KM, Gallistl S, Weinhandl G, Muntean W, Borkenstein MH. Relationship between plasminogen activator inhibitor-1 antigen, leptin, and fat mass in obese children and adolescents. Metabolism 2000; 49(7):890-5.

Facchini F, Chen I, Hollenbeck CB, Reaven GM. Relationship between resistance to insulin-mediated glucose uptake urinary uric acid clearance, and plasma uric acid concentration. JAMA 1991; 266:3008-11.

Clausen JO, Borch-Johnsen K, Ibsen H, Pedersen O. Analysis of the relationship between fasting serum uric acid and the insulin sensivity index in a population-based sample of 380 young healthy Caucasians. Eur J Endocrinol 1998; 138:63-9.

Zimmet P, Collins V, de Courten M, et al. Is there a relationship between leptin and insulin sensivity independent obesity? A population-based study in the Indian Ocean nation of Mauritius. Int J Obes 1998; 21(3):171-7.

Sudi K, Gallistl S, Trobinger M, Reiterer E, Payerl D, Aigner R, et al. Insulin and insulin resistance index are not independent determinants for the variation in leptin in obese children and adolescents. J Pediatr Endocrinol Metab 2000; 13(7):923-32.

Garcia-Mayor RV, Andrade MA, Rios M, Lage M, Dieguez C, Casanueva FF. Serum leptin levels in normal children: relationship to age, gender, body mass index, pituitary-gonodal hormones, and pubertal stage. J Clin Endocrinol Metab 1997; 82(9):2849-55.

Chu NF, Wang DJ, Shieh SM, Rimm EB. Plasma leptin concentrations and obesity in relation to insulin resistance syndrome components among school children in Taiwan – The Tipei Children Heart study. Int J Obes 2000; 24(10):1265-71.

Wallace AM, Mcmahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A, et al. Plasma leptin and the risk of cardiovascular disease in the West of Scotland coronary prevention study. Circulation 2001; 104(25):3052-6.

Moreno LA. Fat distribution in obese and nonobese children and adolescents. J Gastroenterol Nutr 1998; 27(2):176-80.

Owens S, Gutin B, Ferguson M, et al. Visceral adipose tissue and cardiovascular risk factors in obese children has been shown to be more highly correlated with cardiovascular. J Pediatr 1998; 133(1):41-5.

Goran MI, Gower BA, Treuth M, et al. Prediction of intra-abdominal and subcutaneous abdominal adipose tissue in healthy pre-pubertal children and subcutaneous abdominal adipose tissue SA with body composition and anthropometry in children. Int J Obes 1998; 22(6):549-58.

Downloads

Publicado

11-08-2023

Como Citar

Lacroix de OLIVEIRA, C., de MELLO, M. T. ., de Pádua CINTRA, I. ., & FISBERG, M. . (2023). Obesidade e síndrome metabólica na infância e adolescência. Revista De Nutrição, 17(2). Recuperado de https://periodicos.puc-campinas.edu.br/nutricao/article/view/9186

Edição

Seção

Comunicação